Sandoz Group Overview
- Year Founded
-
1886
- Status
-
Public
- Employees
-
23,000
- Stock Symbol
-
SDZ
- Investments
-
16
- Share Price
-
$46.82
- (As of Friday Closing)
Sandoz Group General Information
Description
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.
Contact Information
Website
www.sandoz.comCorporate Office
- Centralbahnstrasse 4
- 4051 Basel
- Switzerland
Corporate Office
- Centralbahnstrasse 4
- 4051 Basel
- Switzerland
Sandoz Group Timeline
Sandoz Group Stock Performance
As of 16-May-2025, Sandoz Group’s stock price is $46.82. Its current market cap is $20.2B with 431M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $46.82 | $45.63 | $30.82 - $49.98 | $20.2B | 431M | 1.36M |
Sandoz Group Financials Summary
As of 31-Dec-2024, Sandoz Group has a trailing 12-month revenue of $10.4B.
|
In Thousands, USD |
TTM 31-Dec-2024 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 21,801,954 | 21,801,954 | 13,825,327 | |
| Revenue | 10,384,000 | 10,384,000 | 9,979,000 | 9,306,000 |
| EBITDA | 699,000 | 699,000 | 826,000 | 1,675,000 |
| Net Income | 0 | 0 | 77,000 | 848,000 |
| Total Assets | 19,907,000 | 19,907,000 | 19,430,000 | 17,557,000 |
| Total Debt | 4,853,000 | 4,853,000 | 4,553,000 | 333,000 |
Sandoz Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sandoz Group Comparisons
Industry
Financing
Details
Sandoz Group Competitors (51)
One of Sandoz Group’s 51 competitors is Viatris, a Corporation company based in Canonsburg, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Viatris | Corporation | Canonsburg, PA | ||||
| Takeda Pharmaceutical | Corporation | Tokyo, Japan | ||||
| AstraZeneca | Formerly PE-Backed | Cambridge, United Kingdom | ||||
| Dr. Reddy's Laboratories | Corporation | Hyderabad, India | ||||
| Sun Pharmaceutical Industries | Corporation | Mumbai, India |
Sandoz Group Patents
Sandoz Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160081937-A1 | Tablet with increased drug load of odanacatib | Inactive | 16-May-2013 | ||
| US-20160106679-A1 | Tablet with increased drug load of odanacatib | Inactive | 16-May-2013 | ||
| US-9730932-B2 | Pharmaceutical composition containing crystalline macitentan | Active | 22-Apr-2013 | ||
| US-20160074398-A1 | Pharmaceutical composition containing crystalline macitentan | Active | 22-Apr-2013 | ||
| DE-19544507-A1 | Cyclosporin containing preparations | Active | 29-Nov-1995 | A61K47/14 |
Sandoz Group Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sandoz Group Investments & Acquisitions (16)
Sandoz Group’s most recent deal was a Merger/Acquisition with Rowex. The deal was made on 06-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rowex | 06-Mar-2024 | Merger/Acquisition | Distributors/Wholesale | ||
| Coherus BioSciences (Cimerli) | 22-Jan-2024 | Merger/Acquisition | Biotechnology | ||
| Astellas Pharma (Antifungal Agent Mycamine in Makati, Philippines) | 30-Jun-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Coalesce Product Development | 14-Mar-2022 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| GSK (Cephalosporin Antibiotics Business) | 11-Oct-2021 | Merger/Acquisition | Pharmaceuticals |
Sandoz Group ESG
Risk Overview
Risk Rating
Updated April, 30, 2025
23.56 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,631
Rank
Percentile
Pharmaceuticals
Industry
of 843
Rank
Percentile
Pharmaceuticals
Subindustry
of 419
Rank
Percentile
Sandoz Group Exits (3)
Sandoz Group’s most recent exit was on 31-Oct-2000 from P-Cube. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| P-Cube | 31-Oct-2000 | Completed |
|
||
| Imutran | 01-Jan-1994 | Completed |
|
||
| Nabriva Therapeutics | Corporate | Completed |
Sandoz Group Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Rowex | Newtown, Ireland | 1993 | |
| Hexal | Holzkirchen, Germany | 1986 | |
| Coherus BioSciences (Cimerli) | Redwood City, CA |
Sandoz Group FAQs
-
When was Sandoz Group founded?
Sandoz Group was founded in 1886.
-
Where is Sandoz Group headquartered?
Sandoz Group is headquartered in Basel, Switzerland.
-
What is the size of Sandoz Group?
Sandoz Group has 23,000 total employees.
-
What industry is Sandoz Group in?
Sandoz Group’s primary industry is Pharmaceuticals.
-
Is Sandoz Group a private or public company?
Sandoz Group is a Public company.
-
What is Sandoz Group’s stock symbol?
The ticker symbol for Sandoz Group is SDZ.
-
What is the current stock price of Sandoz Group?
As of 16-May-2025 the stock price of Sandoz Group is $46.82.
-
What is the current market cap of Sandoz Group?
The current market capitalization of Sandoz Group is $20.2B.
-
What is Sandoz Group’s current revenue?
The trailing twelve month revenue for Sandoz Group is $10.4B.
-
Who are Sandoz Group’s competitors?
Viatris, Takeda Pharmaceutical, AstraZeneca, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries are some of the 51 competitors of Sandoz Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
